Pharmacy funding Where are we now and what next Department of Healths view Reaction from the profession Reaction from the press The LPCs plan Agenda INTRODUCTION The role of community pharmacy ID: 599053
Download Presentation The PPT/PDF document "Tees LPC" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Tees LPC
Pharmacy funding
Where are we now and what next?Slide2
Department of Health’s view
Reaction from the profession
Reaction from the pressThe LPC’s plan
AgendaSlide3
INTRODUCTION
The role of community pharmacy
Community pharmacy already plays a vital role in:
- Dispensing medicines
- Advising on medicines use
- Promoting good health and supporting the prevention
agenda
- Supporting people to look after themselves
But it could play an even greater role, as part of more
integrated local care models, in:
- Optimising medicines usage
- Supporting people with long term conditions
- Treating minor illness and injuries
- Taking referrals from other care providers
- Preventing ill health
- Supporting good health
Key facts and figures
1.6 million
visits to community pharmacy every
day, of which 1.2 million are for health reasons
Around
1 billion
medicines dispensed incommunity pharmacy every year
£8 billion spend every year in primary care onNHS medicines
2.5% current yearly rate of prescription growth
Medicines optimisation
Up to half of patients don’t use medicines in theway intended; many are simply thrown away
1 in 7 over 75s are admitted to hospital becauseof incorrect medicines use
70% of people in care homes may be at risk frommedication errors
DH - Leading the nation’s health and care
9Slide4
PHARMACY AT THE HEART OF THE NHS
Pharmacy at the heart of the NHS
The vision is for community pharmacy to be integrated with the wider health and social care system. This will
help relieve pressure on GPs and Accident and Emergency Departments, ensure optimal use of medicines, and
will mean better value and patient outcomes. It will support the promotion of healthy lifestyles and ill health
prevention, as well as contributing to delivering seven day health and care services.
- Pharmacists enabled to practise more clinically - irrespective of setting and including in community pharmacy
- and optimising medicines in a way which puts patients at the centre of decision making, with regular
monitoring and review.
- Clinical pharmacists in GP practices, able to prescribe medicines and working side by side with GPs, supporting
better health and prevention of ill-health.
- Clinical pharmacists working in care homes, working with residents and staff to make the most of medicines.
- Clinical pharmacists helping patients who have urgent problems, at the end of the phone - for example via the
111 service or on the internet.
- Easier for patients to get their prescriptions, for example via the internet where a patient feels this would be
more convenient for them.
- Pharmacists freed up to support patients to make the most of their medicines, promote health and provide
advice to help people live better, harnessing the skills of the wider pharmacy team to support and deliver high
quality patient centred health and care.
The direction of travel around strengthening clinical practice and medicines optimisation is in keeping with what is
expected of hospital pharmacy.
DH -
Leading the nation’s health and care
10Slide5
EFFICIENCY IN COMMMUNITY PHARMACY
NHS funding for community pharmacy
Amount (£ million)
- The NHS has committed £2.8bn
in
2015/16 on remuneration funding
for community pharmacy.
- £2bn in fees and allowances, with
a further £800m distributed
through margin on drug
reimbursement.
1.4% 0.9%
4.3% 4.9%
13.5%
43.5%
31.7%
Practice payments (£633m)
Dispensing fees (£869m)
Directed Medicines Use Reviews and
other advanced services (£86m)
Electronic prescription allowance (£28m)
Repeat dispensing annual payments
(£17m)
Special fees and other allowances (£97m)Establishment payments (£270m)
- The median average pharmacy receives £220,000 a year in NHS fees and allowances (including
margin).
- In the context of the NHS needing to deliver £22 billion in efficiency savings by 2020/21, we haveto examine community pharmacy and the contribution it can make to this challenge.
DH - Leading the nation’s health and care
13Slide6
EFFICIENCY IN COMMUNITY PHARMACY
Efficiency in community pharmacy
14,000
- There are 11,674 pharmacies in England (at
31 March 2015 )
This is an almost 20%
increase since 2003
, when there were 9,748
.
-
The NHS funds this growing estate while
there is low uptake of digital channels
- out
of step with how other public sector services
have developed over the past 10 years .
-
40% of pharmacies are in clusters of 3 or
more meaning that two-fifths of pharmacies
are within 10 minutes walk of 2 or moreother pharmacies, each being supported by
NHS funds.
- Technology is increasingly being used to
assemble prescriptions, in individual
pharmacies, in small hubs by small groups,and by large organisations, but the current
rules mean some forms of technologycannot be accessed by all pharmacies.
12,00010,000
8,0006,000
4,000
2,0000
2006/07 2007/08 2008/09 2009/10 2010/11 2011/12 2012/13 2013/14 2014/15Number of community pharmacies Average monthly items per pharmacy
Number of pharmacies and average monthly items dispensed in England, 2003-2015
Source: Prescriptions Dispensed in the Community, Statistics for England - 2003-2013 [NS]
DH -
Leading the nation’s health and care
14Slide7
PROPOSALS FOR CHANGE IN COMMUNITY PHARMACY
Remuneration funding for community pharmacy in 2016/17
Spending on health continues to grow, and the Spending Review announced a £10 billion real terms increase in NHS
funding in England between 2014/15 and 2020/21, of which £6 billion will be delivered by the end of 2016/17. In
the Spending Review, the Government also re-affirmed the need for greater efficiency and productivity, and the
need for the the NHS to deliver £22 billion efficiency savings by 2020/21, as set out in the NHS’s own plan, the Five
Year Forward View. Community pharmacy must play its part in delivering those efficiencies.
The Government believes these efficiencies can be made without compromising the quality of services or public
access to them because:
-
there are more pharmacies than are necessary to maintain good patient access
-
most NHS funded pharmacies qualify for a complex range of fees, regardless of the quality of service and levels
of efficiency of that provider
- more efficient dispensing arrangements remain largely unavailable to pharmacy providers
In 2016/17, the total funding commitment for pharmacies under the community pharmacy contractual
framework (essential and advanced services) will be no higher than £2.63bn, compared to £2.8bn in 2015/16.
The Government is consulting on proposals to realise its objective of a more clinically focussed, modern and
efficient pharmacy sector, delivered within the £2.63bn of funding under the Community Pharmacy Contractual
Framework.
DH -
Leading the nation’s health and care
15Slide8
PROPOSALS FOR CHANGE IN COMMUNITY PHARMACY
Proposals for change in community pharmacy
17 December 2015 marked the start of our consultation with the PSNC, other pharmacy bodies and others,
including patient and public representatives, on changes to community pharmacy, achieved within the £2.63bn
funding cap described previously.
Our aim is that these changes will:
- Integrate community pharmacy and pharmacists more closely within the NHS, optimising medicines use
and delivering better services to patients and the public.
- Modernise the system for patients and the public - making the process of ordering prescriptions and
collecting dispensed medicines more convenient for members of the public by ensuring they are offered
a choice in how they receive their prescription.
- Ensure the system is efficient and delivers value for money for the taxpayer.
-
Maintain good public access to pharmacies and pharmacists in England.
The following slides provide more information on our proposals to achieve these objectives on which we would
welcome your views.
DH -
Leading the nation’s health and care
16Slide9
PROPOSALS FOR CHANGE IN COMMUNITY PHARMACY
Bringing pharmacy into the heart of the NHS
Pharmacists’ skills make them invaluable to patients and the public, but too often those skills are not used effectively,
resulting in avoidable hospital admissions, medicines wastage and sub-optimal care. NHS England has taken important steps
to integrate pharmacy into the NHS and the Government would like to make further progress.
We will work closely with the PSNC, other pharmacy bodies and others, including patient and public representatives, on how
best to introduce a Pharmacy Integration Fund (PhIF). This will be the primary means of driving transformation of the
pharmacy sector to embed medicines optimisation and the practice of clinical pharmacy in primary care, bringing clear
benefits to patients and the public.
The proposal for year one will be to focus particularly on the key enablers to achieve integration of community pharmacy. It
will be spent primarily on supporting the deployment of clinical pharmacists in a range of primary care settings, including GP
practices, multi-speciality community providers, urgent care hubs, care homes and NHS 111. We believe this will be
fundamental to fully integrating community pharmacy into the NHS through the creation of clinical and professional links to
community pharmacists, together with referral pathways. In addition, it is envisaged the fund will support a range of
activities, including:
- Developing the delivery of high quality, clinically focussed pharmacy services that are integrated within wider primary
care, including community pharmacy;
- Integration of the seven principles of medicines optimisation into care pathways for long term conditions such as
diabetes, COPD, asthma and hypertension including opportunities for health improvement and wellbeing;
- Developing, collaboratively with Health Education England, the whole pharmacy workforce to make patient facing roles
the norm;
- Supporting the development and implementation of digital technologies for community pharmacy so that it has the
infrastructure to achieve integration with clinical pathways and medicines optimisation for patients;
- Developing clinical pharmacists working in GP practices, care homes and primary care urgent care hubs (e.g. NHS 111);
- Evaluation of innovative clinical pharmacy services, including those already provided by community pharmacies and those developed through the PhIF;
- Working with Public Health England to develop the value proposition for community pharmacy to encourage the
commissioning of local health and wellbeing services by local authorities with a focus on the Healthy Living Pharmacy
model.DH - Leading the nation’s health and care
17Slide10
PROPOSALS FOR CHANGE IN COMMUNITY PHARMACY
Bringing pharmacy into the heart of the NHS (2)
We welcome views on these proposals, and further proposals from the pharmacy sector, and others, including patient
and public representatives, on bringing pharmacy into the heart of the NHS to deliver better quality services to
patients and the public.
What are your views on the introduction of a Pharmacy Integration Fund?
What areas should the Pharmacy Integration Fund be focussed on?
How else could we facilitate further integration of pharmacists and community pharmacy with other parts of the NHS?
DH -
Leading the nation’s health and care
18Slide11
PROPOSALS FOR CHANGE IN COMMUNITY PHARMACY
Modernising the system to maximise choice and convenience for patients and the
public
Online ordering, click and collect and home delivery are all growing significantly in other sectors and online retail
sales grew by 16% in the UK in 2014. However, the uptake of digital ordering, click and collect and home delivery in
community pharmacy remains low. The Office of National Statistics estimate that less than 10% of adults ordered
their medicines online in 2014.
Because of this, the Government wants to ensure that the regulatory framework and payments system facilitates
online, delivery to door and click and collect pharmacy and prescription services.
These services already exist to an extent within the community pharmacy sector. As part of our consultation we want
to consider how we can promote patient choice and convenience when ordering prescriptions, creating a seamless
digital journey for all patients, where the choice of delivery or collection is made upfront.
Specifically we want to consider proposals to:
-
ensure patients are offered the choice of home delivery or collection when ordering their prescription;
-
introduce a new terms of service for distance-selling pharmacies in recognition of the difference in their service
offering, and thus differentiated payment.
To what extent do you believe the current system facilitates online, delivery to door and click and collect pharmacy and
prescription services?
What do you think are the barriers to greater take-up?
How can we ensure patients are offered the choice of home delivery or collection of their prescription?
DH -
Leading the nation’s health and care
19Slide12
PROPOSALS FOR CHANGE IN COMMUNITY PHARMACY
Making efficiencies
The Government wishes to work with the PSNC and pharmacy organisations to deliver a more efficient and innovative system. As part of
this, we want to consider proposals to:
-
Simplify the NHS pharmacy remuneration payment system
. The current system is complex and does not promote efficient and high
quality services. For example the establishment payment - of around £25,000 per year - is received by all pharmacies dispensing
2,500 or more prescriptions a month, a relatively low prescription volume. This incentivises pharmacy business to open more NHS
funded pharmacies, adding costs to the taxpayer. We therefore propose the establishment payment is phased out over a number of
years.
-
Help pharmacies become more efficient and innovative
through, for example, modern dispensing methods. We will separately
consult on changes to medicines legislation to allow the ‘hub and spoke’ dispensing model across different legal entities. This could
allow independent pharmacies to capture the efficiencies stemming from large-scale, automated dispensing, reduced stock holding
and economies of scale in purchasing and delivery of stock to the hubs, freeing up time to concentrate in the spokes on delivering
patient centred services designed to optimise the use of medicines by patients. These efficiencies could help pharmacies lower their
operating costs and enable pharmacists and their teams to provide more clinical services and to improve and support people’s
health.
- Encourage longer prescription durations, where clinically appropriate
. Where there is no clinical need for a 28-day repeat
prescription, this represents inconvenience to the patient and an avoidable cost to the taxpayer. As part of stable long termcondition management, many prescribers already prescribe 90-day repeat prescriptions where it is clinically appropriate. With a
wider range of interested parties, we will be looking at steps to encourage optimising prescription duration, balancing clinical need,patient safety, avoidance of medicine waste and greater convenience for patients.The above are initial proposals. The Government is open to any proposal that will drive efficiency and innovation in community pharmacy.
What are your views of the extent to which the current system promotes efficiency and innovation?
Do you have any ideas or suggestions for efficiency and innovation in community pharmacy?
What are your views of encouraging longer prescription durations and what thoughts do you have of the means by which
this could be done safely and well?DH - Leading the nation’s health and care
20Slide13
PROPOSALS FOR CHANGE IN COMMUNITY PHARMACY
Maintaining public and patient access to pharmacies
Access to pharmacies in England is excellent - 99% of the population can get to a pharmacy within 20 minutes by car and 96% by
walking or public transport. Access is greater in areas of highest deprivation.
The Government is committed to maintaining access to pharmacies and pharmacy services, and is consulting on its proposal for the
introduction of a Pharmacy Access Scheme, based on a national formula by which qualifying pharmacies, according to an index
based on geography and other factors, will be required to make smaller efficiencies than the rest of the sector.
The proposal is for a national formula to be used to identify those pharmacies that are the most geographically important for
patient access, taking into account an isolation criteria based on travel times or distances, and also population size and needs. The
population needs variables that we propose should be included are as follows:
·
Index of Multiple Deprivation (2015)
·
Proportion of population >75 years who are >85 years
·
Proportion of population >70 years claiming disability living allowance
·
Standardised Mortality Ratios (SMR) by middle super output area
·
Generalised fertility rate
·
Age-sex standardised proportion non-white
·
Age-sex standardised proportion tenure social
·
Age-sex standardised limiting long term illness
Once an index of isolation and population needs is determined, we would then need to determine the means by which pharmacies
would qualify, such as a travel time threshold or similar. The index would then be combined with the chosen qualifying criteria to
generate a list of qualifying pharmacies.
What are your views on the principle of having a Pharmacy Access Scheme?What particular factors do you think we should take into account when designing the Pharmacy Access Scheme?
DH - Leading the nation’s health and care
21Slide14
PROPOSALS FOR CHANGE IN COMMUNITY PHARMACY
Further discussion
Do you have other views you would like to feed into the consultation process?
We welcome feedback from these stakeholder briefing sessions. Please respond to this first phase of the
consultation by Friday 12 February 2016, which will allow us to collate all views received during this
initial period and input them into the ongoing discussions with the PSNC. We are expecting individuals to
input to the consultation via the PSNC and other representative bodies.
We will then hold further stakeholder meetings during March in advance of the consultation period
closing on 24 March.
DH -
Leading the nation’s health and care
22Slide15
Reaction from the profession
https://petition.parliament.uk/petitions/116943
Stop cuts to pharmacy funding and support pharmacy services that save NHS money
39,889
signatures – but slowing down
I am a community pharmacist
! So
far as part of my 9 hour shift today; I have dispensed and given out medication to 367 different people equating to 987 different items,
had a consultation and supplied a patient with emergency contraception,
Counselled 2 people on
the…(Calum
Plenderleith
)Slide16
Reaction from the press
£170m cuts could kill off a QUARTER of our chemists - prompting warning of even more pressure on
A&Es
Many High Street pharmacies in England face closure, says minister
Pharmacists
were meant to be the face of the NHS - but now our jobs are at risk
Sector's shock at Burt's suggestion of 3,000
closures
Up to 3,000 pharmacies could close after government cuts, MPs warn
One in four pharmacies on the high street face closure
DDA to
scruitinse
effect of pharmacy funding cutSlide17
Do nothing?
Do something…
What are our options?Slide18
Online & Social Media
@
ComPhcyTees 242 followers – many not our pharmacy teams Tees LPC 57 ‘likes’ – we need more
http://psnc.org.uk/tees-lpc/
(or Google Tees LPC)
The LPC’s planSlide19
Fill in the petition
https://petition.parliament.uk/petitions/116943 (or Google pharmacy cuts petition)Write to MP’s
Template for pharmacy Template for pharmacy team members
Other material
NPA (for independent pharmacies)
Head Office (for multiple pharmacies)The LPC’s planSlide20
Visit MP’s and other local decision makers
Local press engagement
Speak to the patient groups (Healthwatch) and ask for their supportWhat other ideas have you got?
The LPC’s planSlide21
Three ideas of how we can:
Get our patients’ support
Get other health care professionals’ supportAnyone else and how
Group discussionSlide22
10am 9 February 2016
Proposals for Community Pharmacy review 2016/2017 and negotiation with the
DoHPSNC proposalsSlide23
Community Pharmacy
Review
2016/17A summary of
PSNC’s service
development proposals
to
the
Department
of Health and NHS EnglandSlide24
Introduction
On 17th December
2015
the Department
of Health
(DH)
and NHS England
wrote
a joint open letter to PSNC entitled Community
pharmacy in 2016/17 and beyond. In the
letter the Government announced that funding for community
pharmacy in 2016/17 would be cut by £170m, from £2.8bn to £2.63bn,
which is a reduction of more than 6% in
cash terms.PSNC is
working with the other national community pharmacy organisations and the
Royal Pharmaceutical Society to respond to the Government’s proposals and
to coordinate a campaign against the aspects of the proposals
which will have an adverse impact on patient
services and access to community pharmacies.Further
information on the Government’s proposals and PSNC response can
be found on the PSNC
website.The open letter
stated:There is real potential for far greater use of community pharmacy and
pharmacists: in prevention of ill health; support for healthy living; support for self-care for minor ailments and long term conditions; medication reviews in care homes; and as part of more integrated local care models.
To this end we need a clinically focussed community pharmacy service that is better integrated with primary care. That will help relieve the pressure on GPs and Accident and Emergency Departments, ensure optimal use of medicines, better value and better patient outcomes,
and contribute to delivering seven day health and care services.As DH and NHS England have
no specific proposals on how to develop
a clinically focussed community pharmacy service, PSNC agreed to submit proposals for discussion. This
document summarises the proposals that PSNC has made to DH and NHS England.Slide25
The
context for
PSNC’s proposals
When the
2005 Community
Pharmacy
Contractual
Framework
(CPCF) was introduced, there was an agreement that it would evolve to respond to the needs of patients and the NHS and
to reflect the desire of the profession to build more services around the dispensing
service.While the CPCF has developed with the addition of new clinical services, including the New Medicine Service and the Seasonal Flu Vaccination Service, it has
not yet developed as far as pharmacy contractors and PSNC would wish.
In 2012 PSNC agreed a clear Vision of its aims and aspirations for the community pharmacy service, with community
pharmacy teams helping people to optimise their use of medicines, supporting their health and care for acute and long-term conditions, allowing them
to live independently in their own homes and providing individualised information, advice and assistance to support the public’s health and healthy living. psnc.org.uk/vision
A 2012 survey
of community pharmacy contractors confirmed that the majority of the sector (98%
of respondents) supported this aspiration for
community pharmacy and since then PSNC has been working towards this vision by
seeking to develop the community pharmacy service across
four key domains:
In
2015
PSNC proposed five immediate service developments that NHS England could implement in its Pharmacy 5 Point Forward Plan. Our service
development proposals to DH draw on this plan.psnc.org.uk/5pointplanSlide26
The PSNC
proposalsThese
proposals set out how the
CPCF could develop
in
order
to meet
DH and NHS England’s stated aims of developing a
more clinically focused community
pharmacy service while also meeting the other ‘efficiency and
productivity’ requirements set out in their
letter of 17th December 2015.
They have been presented to DH and NHS England as outline
proposals to prompt further discussions with PSNC. We will undertake further development work
on the proposals, subject to the response they receive from
DH and NHS England.The
proposals are set out in three
phases, in recognition of the need to allow the wider NHS and
community pharmacy to adopt them in a controlled manner that
also allows time for other
enablers, such as IT, to
be put in place.
We recognise that implementing these service development proposals would have substantial implications for DH’s
planned restructuring of funding delivery and this would require detailed consideration.
PSNC is publishing this summary of the service development proposals so that contractors
and their teams are kept abreast of potential development
of the CPCF and have time to consider how they may impact on their
practiceSlide27
Phase 1 –
Community
Pharmacy Care Package
Transfer
from
Repeat
Prescribing
to eRepeat
Dispensing
(eRD
)
and the
development
of a
community
pharmacy
care package for
patientsUse of electronic repeat dispensing
becomes the default prescribing option where
the prescriber wishes to prescribe on a long-term
basisThe
duration of each supply to the patient is determined by the pharmacist and
patient, with guidance from the prescriber, in order to ensure it is based on clinical need and to seek
to avoid unintended wastage of medicinesPatients
are registered with an individual pharmacy to allow a
patient centred/holistic approach to supporting their use of medicines/ management of
LTCsFunding mechanism for the care package must ensure there is no
drive to dispense prescriptions where the patient has no need for themSlide28
Phase 1 –
Community
Pharmacy Care Package
Medicines
optimisation
support
provided
regularly
MUR-type
conversations
with the
patient
may
be
required,
including
at the start of the process,
and NMS-type interventions would be provided as required
Synchronisation of patient’s
medicines undertaken to support adherence and
reduce wastePatient Activation Measure (PAM) and adherence
scores would be used to indicate the impact of pharmacy interventions, including on the patient’s engagement with their health
This will assist the targeting of pharmacy engagement with the patient to
improve adherence and optimise use of their
medicines, allowing the patient to set their own motivational
goalsSlide29
Phase 1 – Inhaler
technique
checks/coaching
Offer
of an inhaler
technique
check and
coaching
session
to
patients
prescribed
inhalers using
eRD
at
least twice a
year
A formal system for
referral back to the prescriber would be implemented
for circumstances where a referral is clinically
necessarySlide30
Phase 1
–
Prescription Interventions
Pharmacies already
make
interventions
on
prescriptions
These are
communicated
to
the prescriber
but are not
always
clearly
recorded
in
patients’ pharmacy records
Information on the interventions is not
centrally collated and thereforethe
value of these interventions cannot be determined
Under this proposal such interventions would now be clearly recorded using a standard
classification system and the data would be centrally collatedNational and local (CCG) guidance would
be provided to pharmacies on target interventions
Not dispensed interventions would fall within the remit of this proposalSlide31
Phase 1 –
Post-discharge
MURs/medicines reconciliation
Post-discharge
MURs
should
continue
to
be
provided
Numbers
should increase as
communications between hospital
and
community pharmacies
improve
For
some patients a full
MUR may not be required, but a medicines reconciliation
(conducted by support staff) would be
of benefit to all patientsFurther work is required
to determine the optimal approach to supporting patients post-discharge and this may be a candidate for
support from the Pharmacy Integration FundSlide32
Phase 1
–
Pharmacy First service
Minor Ailments
Advice Service & an
Emergency
Supply
Service
To
effectively
implement such
a service,
review
and
implementation
of
amended
NHS 111
referral pathways would
be required in order to support the
referral of more patients to the
serviceFurther development of IT
infrastructure would also be beneficial to support referrals and messaging between NHS 111
sites and community pharmaciesThis is an area which the Pharmacy Integration Fund
could supportSlide33
Phase 1
–
Public Health Campaigns
PHE and NHS
England
should
agree
up
to
six
national campaign topics
each
year,
utilising
PHE’s
portfolio
of national
campaignsEach campaign could run within
pharmacies for up to 2
monthsThis approach would
allow PHE to deliver a consistent
campaign message across the whole pharmacy network reaching millions of people at onceSlide34
Phase 2 – Enhanced
community
pharmacycare package for patients
All pharmacies will
need
to have
SCR access
in
place
and
have to provide
the
national flu
vaccination
service
Building on
the development
of
the
care package in phase 1, additional elements would
be provided to patients registered to receive
the serviceThese elements would support the development of a pharmacy care
plan with the aim of optimising the patient’s use of medicines, treatment of their condition and improvement of their patient activation
scoreSlide35
Phase 2 – Enhanced
community
pharmacycare package for patients
Examples would
include assessing
CAT
and ACT
scores
for
patients
with
COPD
and
asthma, frailty
and
falls
assessments
and use
of other screening tools (building on the work of the Community Pharmacy Future
projects)Use of
these tools would allow the assessment of the
impact of the community pharmacy support on the patient
and their conditionAs appropriate an annual MUR-type review may
be undertaken and NMS interventions would be provided when patients commence new therapiesMost of the interventions would
be provided on an ongoing and regular basis, generally as patients present in the pharmacy to
obtain their next supply of medicinesSlide36
Phase 2 –
Healthy
Living Pharmacy or equivalent accreditation
In
order
to
support the
effective
provision
of
public health
campaigns,
pro-active
healthy
living advice and locally commissioned
public health
services,
pharmacies
will work towards achieving an HLP equivalent accreditation
The training of support staff
as health champions will provide them with the skills to effectively support
behaviour change by patients and the public, related to
both healthy living and medicines optimisationA deadline by which
pharmacies must be accredited would be set and an ongoing requirement to ensure that accreditation is
maintainedSlide37
Phase
3
During
this phase the
service
developments proposed
in Phase 1 and 2
would continue
to
be
provided
Pharmacies
would
additionally
provide support to specific groups of patients to manage long
term conditions, e.g. hypertension and asthma, and more advanced support for frail and older people with multiple conditions
This would release further GP practice capacity but it would also require the majority
of community pharmacists to be qualified as independent prescribers (or for the Alberta approach to
prescribing qualification to be adopted)Slide38
Other
service
developments and the future
DH has identified the
provision
of additional clinical pharmacy
support
for care
homes as one area that needs to be
taken forward.PSNC believes community pharmacy can provide some
of the necessary support required by care homes and
patients living within them, but the approach to team
working with general practice would need to be
explored in order to maximise the
value provided to patients and the NHS.This is work that could
initially be explored using funding from the Pharmacy
Integration Fund.Overall,
the outline proposals set out here represent a starting point for
discussions with DH and NHS England. They describe how community pharmacy teams could make
a more significant contribution to patient care.
At
this time of financial strain and increasing demand
we believe they are ideas that DH and NHS England cannot afford
to ignore.Slide39
Business as usual
Current advanced services
Current local enhanced servicesThreat or Opportunity?What next?Slide40
Questions
Remarks
CommentsThank you!Slide41
Thank you